Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer

NCT07290621 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Oropharyngeal Cancer

Interventions

DRUG: Toripalimab
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

University of Chicago